| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +117K | 100% | $2.33 | +$272K |
| Sells | 0 | ||||
| Net | +4 | +117K | 100% | +$272K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marvin Slosman | CEO and President, Director | $5.86M | +$25K | +0.43% | Jul 30, 2025 |
| Craig Shore | CFO and CAO | $2.23M | Jan 7, 2025 | ||
| Paul Stuka | Director | $1.68M | +$71.8K | +4.47% | Nov 12, 2025 |
| Gary S. Roubin | Director | $1.58M | +$100K | +6.78% | Oct 7, 2025 |
| Shane Gleason | Chief Commercial Officer | $1.3M | Jan 7, 2025 | ||
| Andrea Tommasoli | Chief Operating Officer | $1.25M | Jan 7, 2025 | ||
| Michael Lawless | Chief Financial Officer | $1.13M | Jun 25, 2025 | ||
| Thomas J. Kester | Director | $1.02M | +$75K | +7.95% | Sep 15, 2025 |
| Michael Berman | Director | $982K | Jun 29, 2025 | ||
| Patrick Verta | EVP Clinical/Medical Affairs | $578K | Jan 7, 2025 | ||
| Kathryn Arnold | Director | $544K | Jan 7, 2025 | ||
| Danny L. Dearen | Director | $140K | Sep 16, 2025 | ||
| Raymond W. Cohen | Director | $118K | Jul 31, 2025 | ||
| Campbell Rogers | Director | $70.8K | Oct 13, 2021 | ||
| Scott R. Ward | Director | $60.2K | Jan 7, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|